Analysis Helping poorer countries make locally informed health decisions BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3651 (Published 16 July 2010) Cite this as: BMJ 2010;341:c3651 Article Related content Metrics Responses Peer review Related articles News In brief Published: 21 April 2005; BMJ 330 doi:10.1136/bmj.330.7497.920 See more Covid-19: Omicron infection is poor booster to immunity, study finds BMJ June 15, 2022, 377 o1474; DOI: https://doi.org/10.1136/bmj.o1474 How are vaccines being adapted to meet the changing face of SARS-CoV-2? BMJ June 01, 2022, 377 o1257; DOI: https://doi.org/10.1136/bmj.o1257 Monkeypox: What do we know about the outbreaks in Europe and North America? BMJ May 20, 2022, 377 o1274; DOI: https://doi.org/10.1136/bmj.o1274 Covid-19: Second boosters may benefit at-risk groups but have “minimal” impact for others, says WHO BMJ May 19, 2022, 377 o1259; DOI: https://doi.org/10.1136/bmj.o1259 David Oliver: Protecting healthcare workers in future pandemics BMJ May 18, 2022, 377 o1200; DOI: https://doi.org/10.1136/bmj.o1200 Cited by... Adaptive health technology assessment to facilitate priority setting in low- and middle-income countriesFulltext PDF The NHS: assessing new technologies, NICE and value for moneyFulltext PDF Abstract
